Cancer Cell

Top Research Topics at Cancer Cell?

Cancer research, Cancer cell, Immunology, Cell biology and Cancer are the subjects of interest in Cancer Cell. The journal facilitates discussions on Cancer research that incorporate concepts from other fields like Carcinogenesis, Signal transduction, Metastasis, Cell cycle and Leukemia. The studies in Leukemia featured incorporate elements of Myeloid and Myeloid leukemia.

While Cancer cell is the focus of it, it also provided insights into the studies of Breast cancer and Bioinformatics. While the journal focused on Immunology, it was also able to explore topics like Angiogenesis and Stem cell. In Cancer Cell, Apoptosis, Transcription factor, Cell growth and Molecular biology are investigated in conjunction with one another to address concerns in Cell biology research.

• Cancer research (60.76%)
• Cancer cell (26.30%)
• Immunology (19.09%)

What are the most cited papers published in the journal?

• Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 (4896 citations)
• Tensional homeostasis and the malignant phenotype. (2962 citations)
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis (2773 citations)

Research areas of the most cited articles at Cancer Cell:

The published articles focus largely on the fields of Cancer research, Immunology, Cell biology, Cancer and Signal transduction. The study of Cancer research in the most cited publications encompasses disciplines such as Metastasis, as well as fields such as Breast cancer, all of which overlap with one another. The works on Immunology tackled in the most cited papers bring together disciplines like Angiogenesis and Stem cell.

What topics the last edition of the journal is best known for?

• Gene
• Cancer
• Internal medicine

The previous edition focused in particular on these issues:

The journal tackles a plethora of topics, such as Cancer research, Cancer, Cancer cell, Immune system and MEDLINE. The Cancer research research presented in it explores the relationship between Cytotoxic T cell and the closely related topic of CD8. Cancer research presented in it encompasses a variety of subjects, including Antibody, Immunology, Computational biology and Immunity.

Immunology research is concerned with Vaccination in particular. Cancer cell research discussed connects with the study of Pancreatic cancer. It focuses on MEDLINE but sometimes tackles the closely related topic of Oncology which is concerned with Breast cancer.

The most cited articles from the last journal are:

• Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities (54 citations)
• The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. (42 citations)
• Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer (34 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Cancer Cell (based on the number of publications) are:

• Gordon B. Mills (38 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Mien Chie Hung (34 papers) absent at the last edition,
• Michael D. Taylor (26 papers) absent at the last edition,
• Michael Karin (25 papers) published 1 paper at the last edition the same number as at the previous edition,
• Ronald A. DePinho (24 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Cell (based on the number of publications) are:

• Harvard University (447 papers) published 25 papers at the last edition, 2 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (238 papers) published 14 papers at the last edition, 2 less than at the previous edition,
• Memorial Sloan Kettering Cancer Center (225 papers) published 18 papers at the last edition, 3 less than at the previous edition,
• University of California, San Francisco (181 papers) published 7 papers at the last edition, 1 more than at the previous edition,
• Brigham and Women's Hospital (148 papers) published 8 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.73% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 39.52% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.98% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.36% of all publications and 28.14% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Cancer Cell Research

A career in the field of cancer cell research can be rewarding and challenging. It involves studying the behaviors, growth, and development of cancer cells. It also involves the understanding of complex biological interfaces, providing a chance to make a significant impact on the health of individuals worldwide. Some positions in this field often require an advanced degree in biological sciences and a certification, like a nursing license. For instance, as per the *west virginia nursing license requirements*, aspiring cancer cell research nurses need a Registered Nursing license to start their careers. Cancer cell researchers work in various settings such as hospitals, pharmaceutical companies, government health agencies, and universities. Work prospects in this area are promising, with employment predicted to grow around 7 percent from now till 2029, much faster than the average for all occupations. In conclusion, the research field is full of opportunities and challenges that can align with your career goals. If you are interested in biology, genetics, and helping improve people's health, then a career in cancer cell research might be right for you. There are many resources available to help you decide, from understanding the licensing requirements to finding the right place to start your research career.